openPR Logo
Press release

Endobronchial Valves Market Projected to Augment at a Notable CAGR during the Forecast Period until 2028

10-08-2018 03:46 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Endobronchial Valves Market Projected to Augment at a Notable

Endobronchial valves are specially designed one-way valves that allow the exhaled air to exit the lungs, but restrict the entry of inhaled air to the lung compartment. The endobronchial valve is used to decrease the lung volume in the condition of lung disease or more specifically emphysema. A commonly endoscopic approach is prescribed rather than thoracoscopic lung volume reduction surgery.

The insertion of the endobronchial valve is performed by a delivery catheter, which is passed from the bronchoscope. An endobronchial valve is designed in such a way that it only prevents air uptake or inflation during the inhalation process, and allows the mucosa and exhaled air to exit or the lungs to deflate during the process of exaltation. The endobronchial valves come in different shapes and designs based on the use. Currently, the endobronchial valves are designed in duckbill and umbrella shape.

Endobronchial Valves Market: Drivers and Restraints

The major factor expected to drive the growth of the endobronchial valves market is growing awareness regarding procedure for bronchoscopic lung volume reduction in various lung-related diseases. The increasing prevalence of tobacco smoking worldwide is consequently expected to contribute to the growth of the endobronchial valves market. The chronic obstructive pulmonary disease (COPD) is one of the major lung disorders. With the growing geriatric population, who are more commonly susceptible to lung disease, the demand for endobronchial valve is expected to increase at a linear speed. Besides, growing air pollution has a significant impact on the increasing number of patients suffering with lung disorders, particularly severe emphysema and advanced emphysema.

This is also considered as one of the major factors fueling the growth of the global endobronchial valves market over the forecast period. Efficiency of the endobronchial valves compared to the standard medical care in lung volume reduction methods and emphysema treatment is the other factor expected to propel the growth of the endobronchial valves market over the forecast period. However, the high cost associated with the procedure coupled with the post-operative adhesion issues associated with the valve are factors expected to restrict the growth of the endobronchial valves market over the forecast period.

Request For Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1534

Endobronchial Valves Market: Overview

The global market for endobronchial valves is still in the nascent stage. The global endobronchial valves market is projected to show steady growth as there is no particular substitute available for endobronchial valves in minimally invasive surgery for lung volume reduction. Due to increasing demand for endobronchial valves, manufacturers of endobronchial valve systems are mainly focused on clinical trials and research and development.

In the forthcoming years, the global endobronchial valves market is expected to witness the entry of few new market players, which will increase the competition in the endobronchial valves market. The growing global population, predominantly geriatric, who are more susceptible to have a lung disease, the market for the endobronchial valves is expected to grow at a steady speed.

Among the two product types, due to the ease in the implanting the duckbill-shaped endobronchial valves is expected to be the leading segment in the global endobronchial valves market over the forecast period. The ongoing clinical trials in various regions as such North America and Europe, especially in the U.K., are projected to offer new growth opportunities for the manufacturers operating in the endobronchial valves market.

Endobronchial Valves Market: Regional Outlook

Geographically, the global endobronchial valves market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the dominant regional market for endobronchial valves owing to increasing healthcare spending and shift towards minimally invasive surgeries. The endobronchial valves market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to the increasing healthcare spending in China and India. Europe is projected to hold second large share in the global endobronchial valves market over the forecast period.

Request For Brochure @ https://www.factmr.com/connectus/sample?flag=B&rep_id=1534

Endobronchial Valves Market: Key Players

The global market for endobronchial valves is consolidated with very few players operating in the global endobronchial valves market. Examples of some of the key players operating in the global endobronchial valves market are Pulmonx Corporation (Zephyr), Spiration Inc, etc.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Analysis @ https://www.factmr.com/report/1534/endobronchial-valves-market

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endobronchial Valves Market Projected to Augment at a Notable CAGR during the Forecast Period until 2028 here

News-ID: 1287828 • Views:

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance

All 5 Releases


More Releases for Endobronchial

Endobronchial Ultrasound Biopsy Market Projected to Show Strong Growth
The Latest Released Endobronchial Ultrasound Biopsy market study has evaluated the future growth potential of Endobronchial Ultrasound Biopsy market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential
Endobronchial Tubes Market to Signify Strong Growth by 2024-2031
The Endobronchial Tubes Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). An endobronchial tube, or ET tube, is a soft malleable plastic tube that is implanted through the mouth or nose into the trachea or windpipe, to help a patient breathe. Moreover, in most exigent circumstances, it's implanted through the mouth. The endobronchial tube is then associated with a ventilator
Endobronchial Valves Market 2025 | Pulmonx Corporation (Zephyr), SpirationInc, e …
Endobronchial valves were developed primarily by the start-up medical device company Emphasys Medical (now Pulmonx - Redwood City, California) as a minimally invasive alternative to lung volume reduction surgery for emphysema. In lung volume reduction surgery, a surgeon cuts into a patient's chest and cuts out one or more diseased portion(s) of a lung. Endobronchial valves were designed to replicate the effects of that procedure without requiring incisions, by simply
Global Endobronchial Ultrasound Biopsy Market Overview & Competitive Research 20 …
ResearchMoz include new market research report "Endobronchial Ultrasound Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its huge collection of research reports. This report analyzes the current and future scenario of the global endobronchial ultrasound biopsy market. Rise in geriatric population, high prevalence of lung cancer and other respiratory-related disorders, and increase in patient preference for minimally invasive surgeries are major drivers of
Endobronchial Valves Market 2025 | Pulmonx Corporation (Zephyr), SpirationInc
Endobronchial valves were developed primarily by the start-up medical device company Emphasys Medical (now Pulmonx - Redwood City, California) as a minimally invasive alternative to lung volume reduction surgery for emphysema. In lung volume reduction surgery, a surgeon cuts into a patient's chest and cuts out one or more diseased portion(s) of a lung. Endobronchial valves were designed to replicate the effects of that procedure without requiring incisions, by simply
Endobronchial Valves Market 2025 | Pulmonx Corporation (Zephyr), SpirationInc,
Endobronchial valves were developed primarily by the start-up medical device company Emphasys Medical (now Pulmonx - Redwood City, California) as a minimally invasive alternative to lung volume reduction surgery for emphysema. In lung volume reduction surgery, a surgeon cuts into a patient's chest and cuts out one or more diseased portion(s) of a lung. Endobronchial valves were designed to replicate the effects of that procedure without requiring incisions, by simply